Document:

Exhibit 4.3 

 

 

CDK
Global, Inc.,
 Issuer,

 

and

 

U.S. Bank Trust Company, National Association,

Trustee

 

 

 

FIRST
SUPPLEMENTAL INDENTURE

 

 

 

Dated as of May 3, 2022

 

 

 

5.250% Senior Notes due 2029

 

 

     

     

    

 

FIRST SUPPLEMENTAL INDENTURE (this “First
Supplemental Indenture”), dated as of May 3, 2022, between CDK Global, Inc., a Delaware corporation (the “Company”),
and U.S. Bank Trust Company, National Association (successor in interest to U.S. Bank National Association), as trustee under the Indenture
referred to below (the “Trustee”).

 

W I T N E S S E T H

 

WHEREAS, the Company has heretofore executed and
delivered to the Trustee an indenture dated as of May 15, 2019 (the “Indenture”), between the Company and the Trustee, pursuant
to which the Company’s 5.250% Senior Notes due 2029 (the “Notes”) were issued;

 

WHEREAS, the Company has entered into the Agreement
and Plan of Merger, dated April 7, 2022, by and among the Company, Central Parent LLC and Central Merger Sub Inc. (“Merger Sub”),
as amended from time to time (the “Merger Agreement”);

 

WHEREAS, in connection with the transactions contemplated
in the Merger Agreement, the Company has offered to purchase for cash any and all outstanding Notes (the “Tender Offer”) pursuant
to the Offer to Purchase and Consent Solicitation Statement dated April 20, 2022, as amended or supplemented from time to time (the “Statement”);

 

WHEREAS, in connection with the Tender Offer,
the Company has requested that Holders of the Notes deliver their consents with respect to the deletion of certain provisions of the Indenture;

 

WHEREAS, Section 9.02 of the Indenture provides
that, subject to certain exceptions inapplicable hereto, the Company and the Trustee may amend or supplement the Indenture and the Notes
with the consent of the Holders of at least a majority in aggregate principal amount of the then outstanding Notes (including, without
limitation, consents obtained in connection with a tender offer for the Notes);

 

WHEREAS, the Holders of a majority in aggregate
principal amount of the Notes outstanding have duly consented to the proposed modifications set forth in this First Supplemental Indenture
in accordance with Section 9.02 of the Indenture;

 

WHEREAS, the Company has heretofore delivered
or is delivering contemporaneously herewith to the Trustee (i) evidence of the written consent of the Holders set forth in the immediately
preceding paragraph and (ii) the Officer’s Certificate and the Opinion of Counsel described in Section 9.06 of the Indenture; and

 

WHEREAS, all conditions necessary to authorize
the execution and delivery of this First Supplemental Indenture and to make this First Supplemental Indenture valid and binding have been
complied with or have been done or performed.

 

NOW, THEREFORE, in consideration of the foregoing
and notwithstanding any provision of the Indenture which, absent this First Supplemental Indenture, might operate to limit such action,
the parties hereto, intending to be legally bound hereby, agree as follows:

 

    2

     

    

 

ARTICLE I

 

AMENDMENT OF INDENTURE

 

Section 1.1     Amendments.

 

(a)       Subject
to Section 2.1 hereof, on the Operative Date (as defined herein) the Indenture is hereby amended by deleting in their entireties Sections
4.03, 4.04, 4.05 and 4.06 and Article V of the Indenture. Effective as of the date hereof, none of the Company, the Trustee or other parties
to or beneficiaries of the Indenture shall have any rights, obligations or liabilities under such Sections or Article, and such Sections
or Article shall not be considered in determining whether an Event of Default has occurred or whether the Company has observed, performed
or complied with the provisions of the Indenture.

 

(b)       Subject
to Section 2.1 hereof, on the Operative Date Section 4.02 of the Indenture is hereby amended and restated to read, in its entirety, as
follows:

 

“Section 4.02. Rule 144A Information.

 

The Company shall comply with the provisions of
TIA § 314(a).

 

(c)       Subject
to Section 2.1 hereof, on the Operative Date Section 6.01 of the Indenture is hereby amended and restated to read, in its entirety, as
follows:

 

“Section 6.01. Events of Default.

 

An “Event of Default” occurs
if:

 

		(1)	the Company defaults in any payment of interest on any Security when the same becomes due and payable, and such default continues
for a period of 30 days; or

 

		(2)	the Company defaults in the payment of the principal of any Security when the same becomes due and payable at its Stated Maturity,
upon optional redemption, upon required purchase, upon declaration of acceleration or otherwise.”

 

(d)       Subject
to Section 2.1 hereof, on the Operative Date Section 8.02(1) of the Indenture is hereby amended and restated to read, in its entirety,
as follows:

 

		“(1)	the Company irrevocably deposits in trust with the Trustee money or U.S. Government Obligations for the payment of principal of and
interest on the Securities to maturity or redemption, as the case may be; provided that upon any redemption that requires the payment
of the Applicable Premium, the amount deposited shall be sufficient for purposes of this Indenture to the extent that an amount is deposited
with the Trustee equal to the Applicable Premium calculated by the Company as of the date of the notice of redemption, with any deficit
as of the date of the redemption only required to be deposited with the Trustee on or prior to the date of the redemption;”

 

Section 1.2     Amendments to Definitions and Section
References.

 

(a)       Subject
to Section 2.1 hereof, on the Operative Date the Indenture is hereby amended by deleting any definitions from the Indenture with respect
to which references have been eliminated as a result of the amendments to the Indenture pursuant to Section 1.1 hereof.

 

(b)       Subject
to Section 2.1 hereof, on the Operative Date the Indenture is hereby amended by deleting therefrom any references to sections or articles
of the Indenture which have been deleted as a result of the amendments to the Indenture pursuant to Section 1.1 hereof.

 

    3

     

    

 

ARTICLE II

 

MISCELLANEOUS PROVISIONS

 

Section 2.1      Effect of First Supplemental
Indenture.

 

This
First Supplemental Indenture shall become a binding agreement between the parties hereto and effective when executed by the parties hereto.
Notwithstanding the foregoing sentence, if and when Notes are accepted for purchase by the Company pursuant to the Tender Offer, the amendments
to the Indenture set forth herein shall become operative only at the time and date (the “Operative Date”) at which (i) the
merger of Merger Sub with and into the Company has been consummated in accordance with the Merger Agreement and (ii) the Notes representing
the delivery of consents pursuant to, and subject to the terms and conditions set forth in, the Statement by registered holders of the
outstanding Notes of at least a majority of the outstanding aggregate principal amount of the Notes that are validly tendered (and not
validly withdrawn at or prior to 5:00 p.m., New York City time, on May 3, 2022, unless extended pursuant to, and subject to the
terms and conditions set forth in, the Statement) are accepted for purchase by the Company pursuant to, and subject to the terms and conditions
set forth in, the Statement. Except as amended hereby, all of the terms of the Indenture shall remain and continue in full force and effect
and are hereby confirmed in all respects. From and after the Operative Date, all references to the Indenture (whether in the Indenture
or in any other agreements, documents or instruments) shall be deemed to be references to the Indenture as amended and supplemented by
this First Supplemental Indenture.

 

Section 2.2      Governing Law.

 

THE LAWS OF THE STATE OF NEW YORK SHALL GOVERN
AND BE USED TO CONSTRUE THIS FIRST SUPPLEMENTAL INDENTURE.

 

Section 2.3      No Representations by Trustee.

 

The recitals contained herein shall be taken as
the statement of the Company, and the Trustee assumes no responsibility for the correctness or completeness of the same.

 

Section 2.4      Counterparts.

 

This First Supplemental Indenture may be executed
in any number of counterparts, each of which shall be an original; but such counterparts shall constitute but one and the same instrument.

 

[Signature Page Follows]

 

    4

     

    

 

IN WITNESS WHEREOF, the parties hereto have caused
this First Supplemental Indenture to be duly executed, all as of the date first written.

 

	 	CDK GLOBAL, INC., as Issuer
	 	 
	 	By:  	 /s/ Lee Brunz
	 	 	Name:  	Lee Brunz
	 	 	Title:	Executive Vice President, General Counsel and Secretary
	 	 
	 	U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee
	 	 
	 	By:	/s/ Andrea Harris
	 	 	Authorized Signatory

 

[Signature Page to 2029 Notes Supplemental Indenture]osh-ex101_288.htm

 

Exhibit 10.1

 

OPTION AWARD AGREEMENT (PERFORMANCE BASED)

OAK STREET HEALTH, INC. OMNIBUS INCENTIVE PLAN

Oak Street Health, Inc. (the “Company”) grants to the Participant named below (“you”) [an Incentive/a Nonstatutory] Stock Option to purchase the number of Shares set forth below (the “Option”), under this Option Award Agreement (“Agreement”).

	
Governing Plan:
	
Oak Street Health, Inc. Omnibus Incentive Plan, as amended from time to time.

	
Defined Terms:
	
As set forth in the Plan, unless otherwise defined in this Agreement

	
Participant:
	
[Name]

	
Type of Option:
	
[Incentive/Nonstatutory] Stock Option

	
Grant Date:
	
[Date]

	
Number of Shares Purchasable:
	
[●]

	
Exercise Price per Share:
	
$[●], which is the Fair Market Value as of the Grant Date

	
Original Expiration Date:
	
[●] years from the Grant Date (or earlier if your Separation from Service occurs before this Expiration Date; see Exercise after Separation from Service below)

	
Exercisability:
	
The Option will become exercisable as follows, as long as you do not have a Separation from Service before the applicable date and or event as set forth on Appendix: Vesting Schedule and, if applicable, subject to the attainment of the criteria specified thereon.

In the event of a Separation from Service due to Disability or Death, any portion of the Option that would have become exercisable within 24 months following the date of such Disability or death based on the target vesting percentage shall automatically become exercisable as of such date and shall remain exercisable in accordance with the following provisions.

 

	
Exercise after Separation from Service:
	
Separation from Service for any reason other than Disability, death, or Cause: Any unexercisable portion of the Option expires immediately and any exercisable portion remains exercisable for 90 days after your Separation from Service for any reason other than Disability, death, or Cause.

Separation from Service due to Disability or death: Any unexercisable portion of the Option expires immediately and any exercisable portion remains exercisable for 12 months after your Separation from Service due to your Disability or death.

Separation from Service for Cause: The entire Option, including any exercisable and unexercisable portion, expires immediately upon your Separation from Service for Cause.

Notwithstanding anything else in this Agreement, the Option may not be exercised after the latest Original Expiration Date set forth above.

 

 

 

OPTION TERMS

	
1.
	
Grant of Option

. 

	
 
	
(a)
	
The Option is subject to the terms of the Plan. The terms of the Plan are incorporated into this Agreement by this reference.

	
 
	
(b)
	
You must accept the terms of this Agreement within 10 business days after the Agreement is presented to you for review by accepting this grant pursuant to the Company’s electronic acceptance procedures. You may not exercise any portion of the Option before you have accepted the terms of this Agreement. The Committee may unilaterally cancel and forfeit all or a portion of the Option if you do not timely accept the terms of this Agreement.

	
 
	
(c)
	
If designated above as an Incentive Stock Option, the Option is intended to qualify as an Incentive Stock Option. To the extent the Option fails to meet the requirements of an Incentive Stock Option or is not designated as an Incentive Stock Option, the Option will be a Nonstatutory Stock Option.

	
2.
	
Exercise of Option

.

	
 
	
(a)
	
Right to Exercise. The Option will be exercisable in accordance with the terms provided in the table above and all the rest of the terms of this Agreement. The Option, to the extent exercisable, may be exercised in whole or in part. The Option may not be exercised after it expires. No Shares will be issued upon the exercise of the Option unless the issuance and exercise comply with all Applicable Laws. For income tax purposes, Shares will be considered transferred to you on the date you properly exercise the Option. Until you have properly exercised the Option and Shares have been delivered, you will not have any rights as a Stockholder for those Shares.

	
 
	
(b)
	
Method of Exercise and Payment. You may exercise the Option by delivering an exercise notice in a form approved by the Company (the “Exercise Notice”). The Exercise Notice must state your election to exercise the Option, the number of Option Shares that are being purchased, and any other representations and agreements that may be required by the Company. Together with the Exercise Notice, you must tender payment of the aggregate Exercise Price for all Shares exercised and all applicable withholding and other taxes. The Option will be deemed to be exercised upon receipt by the Company of a fully executed Exercise Notice and payment of the aggregate Exercise Price and all applicable withholding and other taxes.

	
3.
	
Method of Payment

. If you elect to exercise the Option, you must pay the aggregate Exercise Price, as well as any applicable withholding or other taxes, in accordance with any of the payment methods set forth in Section 6.4(d) of the Plan (or any successor sections) and the Exercise Notice.

 2

 

	
4.
	
Restrictions on Exercise

. 

	
 
	
(a)
	
You may not exercise the Option (i) if it is an Incentive Stock Option and the Plan has not been approved by the Stockholders or (ii) if the issuance of Shares upon exercise or the method of payment for those Shares would constitute a violation of any Applicable Law or Company policy.

	
 
	
(b)
	
Any issuance of Shares under the Option may be effected on a non-certificated basis, to the extent not prohibited by Applicable Law.

	
 
	
(c)
	
If a certificate for Shares is delivered to you under the Option, the certificate may bear the following or a similar legend as determined by the Company:

The ownership and transferability of this certificate and the shares of stock represented hereby are subject to the terms (including forfeiture) of the Oak Street Health, Inc. Omnibus Incentive Plan and an option award agreement entered into between the registered owner and Oak Street Health, Inc. Copies of such plan and agreement are on file in the executive offices of Oak Street Health, Inc.

In addition, any stock certificates for Shares will be subject to any stop-transfer orders and other restrictions as the Company may deem advisable under Applicable Law, and the Company may cause a legend or legends to be placed on any certificates to make appropriate reference to these restrictions. In addition, you acknowledge and expressly agree to the lock-up terms of Section 13.21 of the Plan (and any successor terms).

	
5.
	
Transferability

. You may not transfer the Option in any manner other than by will or by the laws of descent and distribution, and the Option may be exercised during your lifetime only by you.

	
6.
	
Term of Option

. You may not exercise the Option after it expires, and you may only exercise the Option in accordance with this Agreement.

	
7.
	
Taxes

. Regardless of any action the Company may take that is related to any or all income tax, payroll tax, or other tax-related withholding under the Plan (“Tax-Related Items”), the ultimate liability for all Tax-Related Items owed by you is and will remain your responsibility. The Company (a) makes no representations or undertakings regarding the treatment of any Tax-Related Items and (b) does not commit to structure the terms of the Award to reduce or eliminate your liability for Tax-Related Items. You will be required to meet any applicable tax withholding obligation in accordance with the tax withholding terms of Section 13.5 of the Plan (and any successor terms). The Option is intended to be exempt from Section 409A, and this Agreement will be administered and interpreted consistently with that intent and with the terms of Section 13.16 of the Plan (and any successor terms). If you make any disposition of Shares delivered under an Incentive Stock Option under the circumstances described in Code Section 421(b) (relating to certain disqualifying dispositions), you must notify the Company of that disposition within 10 days.

	
8.
	
Adjustment

. Upon any event described in Section 4.2 of the Plan (or any successor section) occurring after the Grant Date, the adjustment terms of that section will apply to the Option.

	
9.
	
Bound by Plan and Committee Decisions

. By accepting the Option, you acknowledge that you have received a copy of the Plan and have had an opportunity to review the Plan, and you agree to be bound by all of the terms of the Plan. If there is any conflict between this Agreement and the Plan, 

 3

 

the Plan will control. The authority to manage and control the operation and administration of this Agreement and the Plan is vested in the Committee. The Committee has all powers under this Agreement that it has under the Plan. Any interpretation of this Agreement or the Plan by the Committee and any decision made by the Committee related to the Agreement or the Plan will be final and binding on all Persons.

	
10.
	
Regulatory and Other Limitations

. Notwithstanding anything else in this Agreement, the Committee may impose conditions, restrictions, and limitations on the issuance of Shares under the Option unless and until the Committee determines that the issuance complies with (a) all registration requirements under the Securities Act, (b) all listing requirements of any securities exchange or similar entity on which the Shares are listed, (c) all Company policies and administrative rules, and (d) all Applicable Laws.

	
11.
	
Miscellaneous

.

	
 
	
(a)
	
Notices. Any notice that may be required or permitted under this Agreement must be in writing and may be delivered personally, by intraoffice mail, or by electronic mail or via a postal service (postage prepaid) to the electronic mail or postal address and directed to the person as the receiving party may designate in writing.

	
 
	
(b)
	
Waiver. The waiver by any party to this Agreement of a breach of any term of the Agreement will not operate or be construed as a waiver of any other or subsequent breach.

	
 
	
(c)
	
Entire Agreement. This Agreement and the Plan constitute the entire agreement between you and the Company for the Option. Any prior agreement, commitment, or negotiation related to the Option is superseded.

	
 
	
(d)
	
Binding Effect; Successors. The obligations and rights of the Company under this Agreement will be binding upon and inure to the benefit of the Company and any successor corporation or organization resulting from the merger, consolidation, sale, or other reorganization of the Company, or upon any successor corporation or organization succeeding to substantially all of the assets and business of the Company. Your obligations and rights under this Agreement will be binding upon and inure to your benefit and the benefit of your beneficiaries, executors, administrators, heirs, and successors.

	
 
	
(e)
	
Governing Law; Jurisdiction; Waiver of Jury Trial. You acknowledge and expressly agree to the governing law terms of Section 13.9 of the Plan (and any successor terms) and the jurisdiction and waiver of jury trial terms of Section 13.10 of the Plan (and any successor terms).

	
 
	
(f)
	
Amendment. This Agreement may be amended at any time by the Committee, except that no amendment may, without your consent, materially impair your rights under the Option. 

	
 
	
(g)
	
Severability. The invalidity or unenforceability of any term of the Plan or this Agreement will not affect the validity or enforceability of any other term of the Plan or this Agreement, and each other term of the Plan and this Agreement will be severable and enforceable to the extent permitted by Applicable Law.

	
 
	
(h)
	
No Rights to Service; No Impact on Other Benefits. Nothing in this Agreement will be construed as giving you any right to be retained in any position with the Company or its Affiliates. Nothing in this Agreement will interfere with or restrict the rights of the 

 4

 

	
 
		
Company or its Affiliates—which are expressly reserved—to remove, terminate, or discharge you at any time for any reason whatsoever or for no reason, subject to the Company’s certificate of incorporation, bylaws, and other similar governing documents and Applicable Law. Any value under the Option is not part of your normal or expected compensation for purposes of calculating any severance, retirement, welfare, insurance, or similar employee benefit. The grant of the Option does not create any right to receive any future awards.

	
 
	
(i)
	
Further Assurances. You must, upon request of the Company, do all acts and execute, deliver, and perform all additional documents, instruments, and agreements that may be reasonably required by the Company to implement this Agreement.

	
 
	
(j)
	
Clawback. All awards, amounts, and benefits received or outstanding under the Plan will be subject to clawback, cancellation, recoupment, rescission, payback, reduction, or other similar action in accordance with the terms of any Company clawback or similar policy or any Applicable Law related to such actions, as may be in effect from time to time. You acknowledge and consent to the Company’s application, implementation, and enforcement of any applicable Company clawback or similar policy that may apply to you, whether adopted before or after the Grant Date (including the forfeiture, clawback, and detrimental conduct terms contained in Section 13.22 of the Plan as of the Grant Date (and any successor terms)), and any term of Applicable Law relating to clawback, cancellation, recoupment, rescission, payback, or reduction of compensation, and the Company may take such actions as may be necessary to effectuate any such policy or Applicable Law, without further consideration or action.

	
 
	
(k)
	
Electronic Delivery and Acceptance. The Company may deliver any documents related to current or future participation in the Plan by electronic means. You consent to receive those documents by electronic delivery and to participate in the Plan through any on-line or electronic system established and maintained by the Company or a third party designated by the Company.

	
12.
	
Your Representations

. You represent to the Company that you have read and fully understand this Agreement and the Plan and that your decision to participate in the Plan is completely voluntary. You also acknowledge that you are relying solely on your own advisors regarding the tax consequences of the Option.

 5

 

 

Appendix: Vesting Schedule

 

Subject to potential reduction as set forth in this Agreement and the Plan, [***]% of the shares issuable upon exercise of this Option shall vest on or after [***] on the date that the Committee certifies the achievement of the Performance Metric for the First Performance Period. 

Subject to potential reduction as set forth in this Agreement and the Plan, [***]% of the shares issuable upon exercise of this Option shall vest on or after [***] on the date that the Committee certifies the achievement of the Performance Metric for the Second Performance Period. 

To determine the portion of the shares issuable upon exercise of this Option that vest, the cumulative [***] for each Performance Period will be compared to the goals set forth below.  If the [***] falls between the threshold and target goals below or between the target and maximum goals below, then the portion of the Option that becomes vested shall be determined based on linear interpolation.

 

					
	
 
	
[***] Levels

	
Performance Period
	
Weight
	
Threshold (25%)
	
Target (50%)
	
Maximum (100%)

	
First
	
[***]%
	
$[***]
	
$[***]
	
$[***]

	
Second
	
[***]%
	
$[***]
	
$[***]
	
$[***]

 

In the event that the Company experiences a Change in Control, unvested Options under this Agreement shall automatically vest at the greater of: (1) the Target Vesting Percentage; or (2) the vesting percentage determined based on the [***] for each Performance Period; provided that, for purposes of such determination under this clause (2), each Performance Period shall be deemed to have ended as of the date of such Change in Control.

In the event of material adverse changes to the Company’s eligibility for payment systems as a result of legislative or regulatory action but not a result of any actions or omissions of the Company, the Committee shall make appropriate adjustments to the Performance Metrics.

Consistent with the terms of the Plan, all designations, determinations, interpretations, and other decisions under or with respect to the terms of the Plan or the Agreement, including this Appendix, shall be within the sole discretion of the Committee, and shall be final, conclusive, and binding upon all persons.

For purposes of this Agreement, the following terms shall have the meaning assigned below:

“First Performance Period” means the period from [***] through [***].

“Performance Metric” means [***]. 

 

“[***]” means [***].

 

“Second Performance Period” means the period from [***] through [***]. 

“Target Vesting Percentage” equals [***]% of the shares issuable upon exercise of this Option.

 

 6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00344-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00344-of-00352.parquet"}]]